STURGIS, Mich. (Michigan News Source) – The Abbott Nutrition plant in Sturgis is back in business after being shut down by the FDA in February and storm damage closed their facility in mid-June only a few weeks after resuming production of baby formula.

Products were recalled and the FDA closed down the Sturgis facility in February because of their investigation into four bacterial infections of infants who had been consuming powdered formula from the Sturgis plant. Two of the babies died.

MORE NEWS: A New Adventure at Sailors Old Growth Pines

The complaints were about the bacteria Cronobacter sakazakii. The FDA shut down the facility with no back up plan on how to produce enough baby formula for the country, and, according to Abbott Nutrition and a lack of proof from the government, without evidence that the plant was the source of the bacterial complaints that were reported to them.

The CDC and the FDA have still not come up with a link between the bacteria infections of the infants and the Sturgis plant and the company has stated that there is “no evidence to link our formula” to the infant illnesses and their facility.

None of the products that were tested prior to distribution tested positive for Cronobacter sakazakii or Salmonella and all finished testing by Abbott and the FDA during inspections came back negative for both. No Salmonella was found at the Sturgis facility and the Cronobacter sakazakii found was in a non-product contact area and did not match the strains of the bacteria taken from samples of the sick infants.

While no link to the sick babies and the Abbott plant were found, the FDA investigation yielded violations in the plant including lax safety protocols which the company has addressed.

The FDA said in a statement recently something they should have figured out back in February when they cut off access of baby formula to mothers across the country by admitting that the Sturgis plant shutdown “compounded by unforeseen natural weather events has shown just how vulnerable the supply chain has become.”

Abbott started producing EleCare on July 1st, a hypoallergenic formula for infants who have severe food allergies and digestive problems, but is not currently producing Similac yet. In-stock powdered baby formula numbers are currently sitting at around 70% across the country.